Coagulation Factor V (F5): Essential Regulator of Blood Clotting Cascade
Endocrinology Diagnostics
Key Summary of Factor V (F5):
Molecular Structure
- Glycoprotein with 330 kDa weight
- Six domains in A1-A2-B-A3-C1-C2 layout
- Stays active 12-36 hours in bloodstream
Synthesis and Activation
- Primarily synthesized in liver hepatocytes
- Activated by thrombin or Factor Xa
- Regulated by Activated Protein C (APC)
Physiological Function
- Critical cofactor in coagulation cascade
- Accelerates prothrombin conversion to thrombin
- Operates in prothrombinase complex on platelet surfaces
Clinical Disorders
- Factor V deficiency causes bleeding tendencies
- Factor V Leiden mutation increases thrombosis risk
- 5% of Caucasians carry Leiden mutation
Diagnostic and Treatment Approaches
- Diagnosed through molecular and activity tests
- Treatment includes plasma transfusions
- Anticoagulation therapy for thrombotic risks
- Ongoing research into personalized genetic therapies
Visit the BioSupply Ltd website for more information on Coagulation Factor V (F5): Essential Regulator of Blood Clotting Cascade